Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus

Design and optimization of a series of 4-(3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-amines: Dual inhibitors of TYK2 and JAK1 - ScienceDirect

Chemical structures of JAK1/2 dual inhibitor Compound 1 and JAK2

Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat

Discovery of 4-piperazinyl-2-aminopyrimidine derivatives as dual inhibitors of JAK2 and FLT3 - ScienceDirect

TK4g is a JAK Inhibitor for Leukemia Cancer Research

Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections

Structure-based design of a phosphotyrosine-masked covalent ligand targeting the E3 ligase SOCS2

Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat

Treating inflammation with the Janus Kinase inhibitor CP-690,550: Trends in Pharmacological Sciences

Molecules, Free Full-Text

The role of ligand efficiency metrics in drug discovery

Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat.